title: Megakaryocytes from chronic myeloproliferative disorders show enhanced nuclear bFGF expression.
authors.forename: Oliver
authors.initials: O
authors.lastname: Bock
authors.forename: Jerome
authors.initials: J
authors.lastname: Schlué
authors.forename: Ulrich
authors.initials: U
authors.lastname: Lehmann
authors.forename: Reinhard
authors.initials: R
authors.lastname: von Wasielewski
authors.forename: Florian
authors.initials: F
authors.lastname: Länger
authors.forename: Hans
authors.initials: H
authors.lastname: Kreipe
mesh_terms: D002467:Cell Nucleus / Q000378:metabolism; D002908:Chronic Disease; D016222:Fibroblast Growth Factor 2 / Q000235:genetics*; D015870:Gene Expression; D006801:Humans; D008533:Megakaryocytes / Q000378:metabolism* / Q000473:pathology; D009196:Myeloproliferative Disorders / Q000473:pathology*; D012333:RNA, Messenger / Q000378:metabolism
chemical_list: D012333:RNA, Messenger; D016222:Fibroblast Growth Factor 2